Article-Journal

An overview of myocardial infarction registries and results from the hungarian myocardial infarction registry
Péter Piros, Rita Dominika Fleiner, Tamás Ferenci, Péter Andréka, H Fujita, P Ofner, Levente Kovács, András Jánosi
Idézet DOI URL
Body composition as a predictor factor of disease outcome in inflammatory bowel disease - Results of 3-year follow up
Á Csontos, Andrea Molnár, Sarolta Dakó, R Hencz, D Piri, Tamás Ferenci, Erzsébet Pálfi, Pál Miheller
Idézet URL
Body composition as a predictor factor of disease outcome in inflammatory bowel disease: results of 3-year follow up
Ágnes Anna Csontos, Andrea Molnár, R Hencz, D Piri, Sarolta Dakó, Tamás Ferenci, Erzsébet Pálfi, Pál Miheller
Idézet URL
Experiences with Using Bayes Factors for Regression Analysis in Biostatistical Setting
Tamás Ferenci, Levente Kovács
Idézet DOI URL
Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
Background Liver disease has become an important cause of morbidity and mortality even in those HIV-infected individuals who are devoid …
Mihály Sulyok, Tamás Ferenci, Mihály Makara, Gábor Horváth, János Szlávik, Zsófia Rupnik, Luca Kormos, Zsuzsanna Gerlei, Zita Sulyok, István Vályi-Nagy
Idézet DOI URL
Infectious hospital agents: A HAI spreading simulation framework
Infectious Hospital Agents (IHA) is an individual-based simulation framework that is able to model wide range of infection spreading …
R Pethes, Tamás Ferenci, Levente Kovács
Idézet DOI URL
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center
Background: CT-P13, the first biosimilar monoclonal antibody to infliximab (IFX), has been confirmed to be efficacious in inducing …
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Milassin, Anna Fábián, Kata Judit Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter László Lakatos, Zoltán Szepes, Tamás Molnár
Idézet DOI URL
Infliximab biosimilar CT-P13 therapy is effective in maintaining clinical remission in Crohn's disease and ulcerative colitis - 54 week data.
Tamás Molnár, Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Milassin, Anna Fábián, Z Végh, Zsuzsanna Kürti, Péter László Lakatos, Zoltán Szepes
Idézet DOI URL
Megjegyzések az adatbányászatról jégkorongcsapatok összeállítása ürügyén
Tamás Ferenci
Idézet URL
Modelling Tumor Growth Under Angiogenesis Inhibition with Mixed-effects Models
Tamás Ferenci, Johanna Sápi, Levente Kovács
Idézet DOI URL